<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03598933</url>
  </required_header>
  <id_info>
    <org_study_id>7053</org_study_id>
    <nct_id>NCT03598933</nct_id>
  </id_info>
  <brief_title>Cricopharyngeal Dysfunction in Adults</brief_title>
  <official_title>Cricopharyngeal Dysfunction in Adults: Diagnostic and Therapeutic Effects of Cricopharyngeal Botulinum Toxin (Botox) Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study, after reviewing the recent literature, is to corroborate the
      thesis of the authors considering the injection of botulinum toxin as a gesture that is both
      diagnostic and therapeutic in the disorders of the Upper Esophageal Sphincter and reinforce
      the results already published with a larger series of patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Deglutition Handicap Index</measure>
    <time_frame>The period from January 1st, 2017 to December 31st, 2017 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Upper Esophageal Sphincter</condition>
  <eligibility>
    <study_pop>
      <textblock>
        - Subject having at least one injection of botulinum toxin A in the crico-pharyngeal muscle
        for Upper Esophageal Sphincter dysfunction in the ENT department and cervico-facial surgery
        of Hautepierre.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman whose age older than 18 years

          -  Dysphagia with solids and / or liquids

          -  Dysfunction of primary or secondary Upper Esophageal Sphincter with indirect
             video-fibroscopy and / or video-fluoroscopy and / or high resolution
             pharyngo-oesophageal manometry

          -  Subject having at least one injection of botulinum toxin A in the crico-pharyngeal
             muscle for Upper Esophageal Sphincter dysfunction in the ENT department and
             cervico-facial surgery of Hautepierre.

          -  Subject who has consented to the use of his data from his medical file for the purpose
             of this research

        Exclusion Criteria:

          -  Myotomy in the first place

          -  Refusal of the subject to participate in the study

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Philippe Schultz, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe Schultz, MD, PhD</last_name>
    <phone>33 3 88 12 76 35</phone>
    <email>philippe.schultz@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sophie Gorostis, MD</last_name>
    <phone>33 3 88 12 76 35</phone>
    <email>sophie.gorostis@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service ORL et chirurgie cervico-faciale</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Schultz, MD, PhD</last_name>
      <phone>33 3 88 12 76 35</phone>
      <email>philippe.schultz@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Schultz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie Gorostis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 16, 2018</last_update_submitted>
  <last_update_submitted_qc>July 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper Esophageal Sphincter</keyword>
  <keyword>botulinum toxin</keyword>
  <keyword>Cricopharyngeal dysfunction</keyword>
  <keyword>Cricopharyngeal botulinum toxin injection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

